Form 4: Crinetics Pharmaceuticals CFO Reports Stock Transaction
Insider Transaction (Form 4)
Tobin Schilke, Chief Financial & Infra. Ofcr. of Crinetics Pharmaceuticals, Inc., reported multiple transactions in common stock on September 1, 2026.
Summary
- Disposition to the issuer: disposed of 7,956 Common Stock at $85.00 ($676,260) on September 1, 2026; holds 71,471 after (Direct).
- Disposition to the issuer: disposed of 71,471 Common Stock at $85.00 ($6,075,035) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 80,000 Stock Option (Right to Buy) at $51.25 ($4,100,000) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 50,000 Stock Option (Right to Buy) at $41.21 ($2,060,500) on September 1, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Tobin Schilke — Officer (Chief Financial & Infra. Ofcr.)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Disposition to the issuer | Common Stock | 7,956 | $85 | $676.3K | 71,471 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 71,471 | $85 | $6.1M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 80,000 | $51 | $4.1M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 50,000 | $41 | $2.1M | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Disposition to the issuer (7,956 shares) |
| 2026-09-01 | Disposition to the issuer (71,471 shares) |
| 2026-09-01 | Disposition to the issuer (80,000 shares) |
| 2026-09-01 | Disposition to the issuer (50,000 shares) |
Keywords
insider transaction, Form 4, CRNX, Crinetics Pharmaceuticals, Inc., neutral, Tobin Schilke
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.